Assembly climbs on quarterly revenue beat
14/08/2026 16:25
BUZZ-Assembly climbs on quarterly revenue beat ** Shares of drug developer Assembly Biosciences ASMB.O advance 4.6% to $31.32
** ASMB's Q2 revenue from collaborative research with Gilead GILD.O rose $13.4 mln from year-ago $9.6 mln
** Analysts' on average expected $8.6 million in revenue, according to LSEG data
** Co says revenue increase includes a $5.1 million catch-up adjustment for updated est. of future activities under the Gilead partnership
** Reports Q2 loss of 20 cents/shr vs est. 65 cents/shr
** Including session's move, stock up 11.8% YTD
(Reporting by Christy Santhosh)